Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy
Clinical trial NCT00509093 · COMPLETED
Trial details
- NCT number
- NCT00509093
- Sponsor
- Case Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2014-05-09
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.